BRCA2 and ovarian carcinoma: Bioinformatic analysis of the Australian Ovarian Cancer Study cohort (OV-AU) dataset suggests a higher incidence of NHEJ in ovarian tumors with low KAT5 expression, in both BRCA2-high and BRCA2-low backgrounds (Fig. 6c).